Pasar al contenido principal

MOLECULAS INMUNOREGULADORAS EN INFLAMACION: FUNCION DE LOS EXOSOMAS EN LA COMUNICACION CELULA-CELULA.

SAF2014-55579-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2014
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO LA PRINCESA
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Adhesive Interactions Delineate the Topography of the Immune Synapse

  • Martín-Cófreces, Noa Beatriz
  • Vicente-Manzanares, Miguel
  • Sánchez-Madrid, Francisco
© 2018 Martín-Cófreces, Vicente-Manzanares and Sánchez-Madrid., T cells form adhesive contacts with antigen-presenting cells (APCs) as part of the normal surveillance process that occurs in lymph nodes and other tissues. Most of these adhesive interactions are formed by integrins that interact with ligands expressed on the surface of the APC. The interactive strength of integrins depends on their degree of membrane proximity as well as intracellular signals that dictate the conformation of the integrin. Integrins appear in different conformations that endow them with different affinities for their ligand(s). Integrin conformation and thus adhesive strength between the T cell and the APC is tuned by intracellular signals that are turned on by ligation of the T cell receptor (TCR) and chemokine receptors. During the different stages of the process, integrins, the TCR and chemokine receptors may be interconnected by the actin cytoskeleton underneath the plasma membrane, forming a chemical and physical network that facilitates the spatiotemporal dynamics, positioning, and function of these receptors and supports cell-cell adhesion during T cell activation, allowing it to perform its effector function., This manuscript has been funded by grants SAF2014-55579-R and SAF 2017-82886-R (FS-M) and SAF2014-54705-R and SAF2017-87408-R (MV-M) from the Spanish Ministry of Economy and Competitiveness; CAM S2017/BMD-3671 from the Comunidad de Madrid (FS-M); ERC-2011-AdG294340-GENTRIS (FS-M); and 2018-IDEAS18018VICE from the Asociación Española contra el Cáncer (MV-M).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Targeting the integrin interactome in human disease

  • Vicente-Manzanares, Miguel
  • Sánchez-Madrid, Francisco
Integrins comprise one of the most important families of cell–cell or cell–matrix adhesion receptors. Integrin interaction with their extracellular ligands is tunable by microenvironment signals, such as chemokines and growth factors, which modulate their interaction with other transmembrane proteins and cytoplasmic interactors. Integrins are important in different disease contexts, particularly inflammatory diseases and cancer. Clinical trials targeting integrins began in the early 2000s, leading to an increasingly clear picture: agents against integrins and their interactome control inflammatory diseases; whereas their efficacy as anti-cancer targets remains dubious. Here, we discuss the success of integrin targeting to treat autoimmunity and its failure in cancer, which is rooted in the plasticity and adaptability of the cancer cell., MV-M acknowledges funding from the Spanish Ministry of Economy and Innovation (MINECO), Grants SAF2014-54705-R and SAF2017-84708-R and from the Universidad de Salamanca (title XI). FS-M research is funded by grants from the Spanish Ministry of Economy and Competitiveness (Grants SAF2014-55579-R and SAF2017-82886-R), CIBER CARDIOVASCULAR from the Instituto de Salud Carlos III (Fondo de Investigación Sanitaria del Instituto de Salud Carlos III with co-funding from the Fondo Europeo de Desarrollo Regional; FEDER), Programa de Actividades en Biomedicina de la Comunidad de Madrid-B2017/BMD-3671-INFLAMUNE and ERC-2011-AdG294340-GENTRIS.